ELDN (Eledon Pharmaceuticals) Pangali Forward P/E

Logo korporat perusahaan Eledon (ELDN)

Eledon Pharmaceuticals (ELDN) specializes in developing agents to prevent transplant rejection and plans to monetize antibodies for the therapy of rare immune pathologies in the future. The company is currently spending its reserves on the final stages of clinical trials, which is creating a financial deficit. The price action on GURU.Markets with the 0.00 indicator clearly demonstrates the impact of these expenditures on the market value of the assets.

Prakiraan rega marang bathi: Eledon Pharmaceuticals, Inc. (ELDN) kanggo 04.07.2022 - 15.11.2026

Rincian analitis perusahaan Eledon Pharmaceuticals

- rega saiki lan proyeksi nilai saham:
Ringkesan analitik perusahaan:eledon.com
Sampel barang Eledon Pharmaceuticals

The success of Eledon Pharmaceuticals (ELDN) correlates directly with the results of antibody clinical trials. The trend of the company's forward P/E ratio reflects the relationship between current market value and projected earnings per share. This indicator measures market expectations regarding the future monetization of R&D expenditures. Low values protect capital, although excessive conservatism may slow portfolio growth. A stable trend confirms the resilience of the business valuation at the current investment level.

Pesaing Eledon Pharmaceuticals (ELDN)

Prakiraan rega marang bathi ARGX (Argenx)|BNTX (BioNTech Group) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E ABVX (Abivax SA)|Kapitalisasi marang proyeksi bathi admabiologics.com (ADMA)|PTGX - Rega marang bathi mangsa ngarep|Immunovant Inc (IMVT) - Prakiraan rega marang bathi|Kiniksa Corp (KNSA) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi Grifols, S.A.|Prakiraan rega marang bathi ADPT|Pangali Forward P/E celldex.com|Rega marang bathi mangsa ngarep Aurinia Pharma (AUPH)|BioCryst Pharmaceuticals - Rasio rega marang bathi mangsa ngarep|Pangali Forward P/E VERA (veratx.com)|Dianthus Pharma (DNTH) - Rasio prakiraan rega marang bathi|PHVS - Rega marang bathi mangsa ngarep|ABCL - Pangali Forward P/E|Tourmaline (TRML) - Rega marang bathi mangsa ngarep|Precigen - Pangali mangsa ngarep rega marang bathi|PHAR (Pharming Group NV) - Pangali Forward P/E|Pangali Forward P/E Nektar Therapeutics|Rega marang bathi mangsa ngarep Upstream Bio Inc (UPB)|Pangali Forward P/E zenasbio.com (ZBIO)|Rega marang bathi mangsa ngarep Immunome Corp IMNM|Pangali Forward P/E Gossamer Bio Inc GOSS|KALV - Rega marang bathi mangsa ngarep|Pangali mangsa ngarep rega marang bathi SEPN (Septerna Pharma)|PVLA (Pieris Pharmaceuticals) - Prakiraan rega marang bathi|Savara Inc. - Pangali mangsa ngarep rega marang bathi|RIGL (Rigel Pharmaceuticals, Inc.) - Pangali Forward P/E|Rega marang bathi mangsa ngarep ANAB|Pangali Forward P/E ATXS|ENGN - Rasio prakiraan rega marang bathi|Pangali Forward P/E RAPT (rapt.com)|Rasio kapitalisasi marang bathi mangsa ngarep JBIO (Aerovate)|Aclaris Therapeutics, Inc - Pangali Forward P/E|Rasio prakiraan rega marang bathi Kyverna Therapeutics Inc.|TLSA: Pangali Forward P/E|CABA - Kapitalisasi marang proyeksi bathi|VTYX (ventyxbio.com) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Theratechnologies Inc. THTX|Prakiraan rega marang bathi AVTX (avalotx.com)|AGEN (Agenus, Inc.) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Climb Bio, Inc. CLYM|Zura Bio Limited (ZURA) - Rasio prakiraan rega marang bathi|ATYR: Prakiraan rega marang bathi|adagene.com (ADAG) - Prakiraan rega marang bathi|Ikena Oncology (IMA) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi Shattuck Labs, Inc.|Rega marang bathi mangsa ngarep equilliumbio.com|Prakiraan rega marang bathi connectbiopharm.com (CNTB)|Pangali Forward P/E IMUX|Kapitalisasi marang proyeksi bathi Atara Bio|Rega marang bathi mangsa ngarep InflaRx N.V. IFRX|X4 Pharmaceuticals - Rega marang bathi mangsa ngarep|ACET: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi CELU (celularity.com)|INMB: Pangali Forward P/E|BRNS: Rasio kapitalisasi marang bathi mangsa ngarep|KZR (Kezar Life Sciences, Inc.) - Pangali Forward P/E|SAB Biotherapeutics Inc. (SABS) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E AKTX|Rega marang bathi mangsa ngarep ENLV (Enlivex Therapeutics Ltd)|Rega marang bathi mangsa ngarep Q32 Bio Inc. QTTB|GOVX - Prakiraan rega marang bathi|EDSA - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi iBio|CARM: Pangali Forward P/E|Rasio rega marang bathi sing dikarepake XTLB (XTL Biopharmaceuticals, Ltd.)|Rega marang bathi mangsa ngarep boltbio.com|Pangali Forward P/E HCW Biologics|Pangali Forward P/E APVO|AIM - Rasio prakiraan rega marang bathi|Pangali Forward P/E ADTX (Aditxt Inc.)|Kapitalisasi marang proyeksi bathi GRI Bio, Inc. (GRI)|XRTX - Rega marang bathi mangsa ngarep|reshapelifesciences.com (HIND) - Prakiraan rega marang bathi|REVB: Pangali Forward P/E|Indaptus Therapeutics, Inc. - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Scinai|Rasio prakiraan rega marang bathi CalciMedica, Inc. CALI|Rega marang bathi mangsa ngarep Affimed NV (AFMD)|Pangali Forward P/E Allakos Inc (ALLK)|Rega marang bathi mangsa ngarep hookipapharma.com HOOK|Pangali Forward P/E IGM Biosciences, Inc. IGMS|iTeos Pharma - Pangali Forward P/E|OCEA - Pangali Forward P/E|TCBP: Pangali Forward P/E|Third Harmonic Bio - Pangali mangsa ngarep rega marang bathi